Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-05-17 @ 8:55 PM
Study NCT ID:
NCT02050594
Status:
COMPLETED
Last Update Posted:
2015-07-07
First Post:
2014-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ipilimumab 12-month Intensive Pharmacovigilance Protocol
Sponsor:
Bristol-Myers Squibb
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CA184-366
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |